Medical/Pharmaceuticals
Prenetics Launches ColoClear, a Non-Invasive Stool DNA Test to Detect Early Signs of Colorectal Cancer in Hong Kong
- Highly sensitive ColoClear test offers convenient screening method that can be completed with simple stool sample at-home, providing an easy alternative to Colonoscopy - Test sensitivity of 96% in colorectal cancer and 64% in advanced adenoma detection in clinical studies - ColoClear is the onl...
2022-06-09 00:56
4600
Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory Board
Promising 'dark matter' cancer therapy has clinical trials in sight DUNEDIN, New Zealand, June 8, 2022 /PRNewswire/ -- Amaroq Therapeutics, a biotechnology company focussed on developing a new class of therapeutics that target lncRNA in cancer, is progressing towards clinical trials following a ...
2022-06-09 00:05
2670
Medison Pharma Announces the Approvals by Health Canada and Therapeutics Goods Administration of KIMMTRAK® (tebentafusp) for the Treatment of Unresectable or Metastatic Uveal Melanoma
KIMMTRAK has been approved in Canada and Australia for the treatment of an
aggressive form of ocular melanoma and follows approval inthe United States and
the European Union
PETACH TIKVAH, Israel, June 8, 2022 /PRNewswire/ -- Today, Medison Pharma
2022-06-08 23:54
3294
Gannex Announces U.S. FDA Clearance of Clinical Trial on FXR Agonist ASC42 for Treatment of Primary Biliary Cholangitis
-- ASC42 has completed Phase I trials in the U.S. and China. This approval from U.S. FDA enables Gannex to complete a critical drug-drug interaction (DDI) study to support upcoming Phase III trials inChina, the U.S. and European Union -- Gannex expects to complete this DDI study at the beginning ...
2022-06-08 20:10
4294
UTSA awards $4 million to Oskar Fischer Prize recipients for innovative explanations of Alzheimer's disease
SAN ANTONIO, June 8, 2022 /PRNewswire/ -- The University of Texas at San Antonio (UTSA) today announced the 10 recipients of the Oskar Fischer Prize, an international competition to expand society's understanding of the causes of Alzheimer's disease. The prize, the world's largest of its kind, to...
2022-06-08 20:05
2572
OnCusp Therapeutics and Multitude Therapeutics Enter into an Ex-China Licensing Agreement for a Potentially Highly Differentiated CDH6-Targeting Antibody Drug Conjugate
NEW YORK, June 8, 2022 /PRNewswire/ -- OnCusp Therapeutics announced today a licensing agreement with Multitude Therapeutics for the development and commercialization of AMT-707 (now referred to as CUSP06), a potentially highly differentiated second-in-class CDH6 antibody drug conjugate ("ADC"). ...
2022-06-08 20:00
2379
Harbour BioMed Announces IND Approval for B7H4x4-1BB Bispecific Antibody
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, June 8, 2022 /PRNewswire/ --Harbour BioMed ("HBM", HKEX: 02142) announced that China National Medical Products Administration (NMPA) had approved the investigational new drug (IND) application to commence phase I trial of its B7H4x4-...
2022-06-08 18:11
2351
Dr Aaron Poh shares Advanced Surgical Techniques for Colorectal Cancer, the Top 3 Most Common Cancer Worldwide
SINGAPORE, June 8, 2022 /PRNewswire/ -- Dr Aaron Poh shares advanced surgical
techniques for Colorectal Cancer. Full text is as follows:
2022-06-08 10:00
2925
FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older
* Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee * If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the first protein-based COVID-19 vaccine availa...
2022-06-08 09:23
4388
Antengene Announces First Patient Dosed in the Phase I STAMINA-001 Study of ATG-037 for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors
SHANGHAI and HONG KONG, June 8, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hema...
2022-06-08 08:30
3327
ASCO 2022 | Ascentage Pharma Releases for the First Time Results of its FAK/ALK/ROS1 inhibitor APG-2449 Demonstrating Safety and Efficacy in Patients with Advanced NSCLC
SUZHOU, China, and ROCKVILLE, MD, June 7, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released the results from its Phase I ...
2022-06-08 08:00
2287
ASCO 2022 | Ascentage Pharma Releases Updated Data Demonstrating Lisaftoclax's (APG-2575) Therapeutic Potential in Patients with R/R CLL/SLL
SUZHOU, China and ROCKVILLE, Md., June 7, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released the updated results from a Pha...
2022-06-08 08:00
2358
First Patient Enrolled in SELUTION SLR IDE BTK Study
LEIPZIG, Germany, June 8, 2022 /PRNewswire/ -- The first patient has been
enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial
involving SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, just
one week after receiving IDE approval.
2022-06-08 08:00
3696
Innovent Announces Phase 2 study of Mazdutide（IBI362） in Chinese Participants with Overweight or Obesity Met Primary and All Key Secondary Endpoints
SAN FRANCISCO and SUZHOU, China, June 8, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ot...
2022-06-08 08:00
4268
Frost & Sullivan Awards EBSCO Information Services for Delivering Innovative Solutions to Access Medical Research Information for Healthcare Providers
Clinical Decisions product suite from EBSCO earns recognition for modern evidence-based resources that support clinical decision-making, enhance patient satisfaction, and improve outcomes SAN ANTONIO, June 7, 2022 /PRNewswire/ -- Based on its recent analysis of the clinical decision support syst...
2022-06-07 21:00
3185
Nature Scientific Reports to publish novel decentralized federated AI learning algorithm that connects globally distributed data silos containing private and poor-quality data
SAN FRANCISCO, June 7, 2022 /PRNewswire/ -- Nature Scientific Reports journal has published results of a new decentralized federated AI learning algorithm from Presagen that can train AI on data that is distributed globally, without having to move private data to a central location. The breakthro...
2022-06-07 20:38
2544
The 3rd BIO International Convention 2022 is Approaching
SAN DIEGO, June 7, 2022 /PRNewswire/ -- With the 3rd BIO International Convention 2022 soon approaching, Neurophth Therapeutics is looking forward to discussing collaboration opportunities in gene therapy for both rare and common ocular diseases. Neurophth Therapeutics is a leading clinical-stag...
2022-06-07 19:23
2549
PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT
SYDNEY, June 7, 2022 Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that a phase II, genomically-guided study of multiple therapies in patients with brain metastases, led by the Alliance for Clinical Trials in Oncology (NC...
2022-06-07 19:00
3171
Molecular Stethoscope, Inc. announces new investment from the Alzheimer's Drug Discovery Foundation
Investment by the ADDF will accelerate the translation of Molecular Stethoscope's cf-mRNA liquid biopsy technology platform into products and services for the diagnosis and management of Alzheimer's disease SOUTH SAN FRANCISCO, Calif., June 7, 2022 /PRNewswire/ -- Molecular Stethoscope, a leadin...
2022-06-07 18:00
2179
Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting
KANAGAWA, Japan, June 7, 2022 /PRNewswire/ -- Chordia Therapeutics Inc. ("Chordia"), a biotech company engaged in the research and development of novel therapies for cancers, today announced that it has presented the interim results from the Phase 1 clinical trial of CTX-712, a selective pan-CDC-...
2022-06-07 14:00
2883
Week's Top Stories
Most Reposted
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1121 media titles]
2026-11-06 22:06
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
[Picked up by 1109 media titles]
2026-11-09 23:00
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
[Picked up by 1083 media titles]
2026-11-10 22:17
Most Read
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
2026-11-13 13:00
115492
Home Companion Robot Mobo to Debut Globally and Open Pre-orders as AiMOGA Showcases Its Robot Family at the 2026 OMODA & JAECOO International User Summit
2026-11-07 13:49
28168
SILVERSEA MARKS HISTORIC OPENING OF THE CORMORANT AT 55 SOUTH, THE SOUTHERNMOST HOTEL ON EARTH, OFFERING A NEW GATEWAY TO ANTARCTICA
2026-11-07 01:05
16425
